DESAI VEERAL (Chief Strategy & Dev. Officer) sold 17.8% of their position (60K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $1.57M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2023ACC: 0001209191-23-019722
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
-60K
Net shares
Net seller
$1.57M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+60K
Price / share
$3.00
Trade value
$180K
% of position
21.7%
3/16/2023
276.73K→336.73K
Common Stock
Direct
Shares
−60K
Price / share
$26.09
Trade value
$1.57M
% of position
17.8%
3/16/2023
336.73K→276.73K
Total
Net shares
+0.00
Net value
-$1.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2023 | M · Option Exercise | +60K | $3.00 | $180K | 21.7% | 276.73K | 336.73K |
| Common Stock Direct | 3/16/2023 | S · Sale | −60K | $26.09 | $1.57M | 17.8% | 336.73K | 276.73K |
| Total | +0.00 | -$1.39M | ||||||
Derivative Transactions1
Options (Rights to Buy)
Direct
Converts to
Common Stock
60K shares
Shares
−60K
Strike price
3.00
Held after
1.64M
Exercisable
—
3/16/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock60K shares | 3/16/2023 | M · Option Exercise | −60K | 3.00 | — | 1.64M |